The study for personnlized medicine using sorafenib with genome analysis
Not Applicable
Recruiting
- Conditions
- Hepatocellular carcinoma and renal cell carcinoma taking sorafenib
- Registration Number
- JPRN-UMIN000017365
- Lead Sponsor
- Department of Pharmaceutical sciences, Tohoku university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
No
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gene (PXR,ABCG1, ABCG2,CYP3A4,CYP3A5) The serum concentration of sorafenib and the metabolites The serum components
- Secondary Outcome Measures
Name Time Method